LifeStance Health Group, Inc. (LFST) on Decifer

Decifer ranks LFST number 71 of 270 tracked names on durable business quality.

Why it ranks here

• Its returns on invested money are modest, around 1% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is expected to grow about 14% a year, profits grew 120% over the past year, and growth is speeding up, not slowing down.
• It keeps a healthy share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• and has the balance sheet to fund its growth.
• We do not have a clean read on how it is run yet.
• Profits up 120% and momentum of 30 out of 35 look lively, but returns near 1%, no funded role, and an unclear read on management limit conviction.

The current read

The evidence on LFST lines up on the supportive side: the intelligence feed flags this name as connected to what is moving markets now. The independent signals we track are telling the same story.

Themes

• Neuroscience & Mental Health Access: Growing recognition and destigmatization of mental health, combined with new neuro-targeted drugs and neurostimulation devices, is expanding demand for both treatment capacity and therapies.

Read the full LFST research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.